DiaSorin (DSRLF)
(Delayed Data from OTC)
$107.40 USD
0.00 (0.00%)
Updated Apr 24, 2024 03:54 PM ET
3-Hold of 5 3
C Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
DSRLF 107.40 0.00(0.00%)
Will DSRLF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DSRLF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DSRLF
New Strong Sell Stocks for January 29th
DSRLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for DSRLF
DiaSorin initiated with bullish view at UBS, here's why
DiaSorin just downgraded at Berenberg, here's why
DiaSorin S.p.A. 2023 Q4 - Results - Earnings Call Presentation
DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
Q3 2023 DiaSorin SpA Earnings Call Transcript